Cholesterol lowering compounds
US5317031A · kind A · utility
15Cited by
2References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 24, 1992 |
| Grant date | May 31, 1994 |
| Priority date | — |
| Expiry date | Nov 24, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H19/01
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Cholesterol lowering compounds and compositions are formed from the photochemical treatment of the Zaragozic Acids followed by esterification. These compounds and compositions are active squalene synthetase inhibitors useful in the treatment of hypercholesterolemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.